@article{JTD18590,
author = {Angelo Onofri and Maxime Patout and Georgios Kaltsakas and Elodie Lhuillier and Sitali Mushemi-Blake and Gill Arbane and Martino F. Pengo and Philip Marino and Joerg Steier},
title = {Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of noninvasive ventilation},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 1},
year = {2018},
keywords = {},
abstract = {Background: Chronic hypercapnic respiratory failure (HRF) in obesity hypoventilation syndrome (OHS) is commonly treated using non-invasive ventilation (NIV). We hypothesised that treatment of OHS would improve neural respiratory drive index (NRDI) and cardiac function.
Methods: Fourteen patients (8 females) with OHS, who were admitted for initiation of domiciliary NIV, were prospectively studied. Patients had (mean ± SD): age (53±10 years), body mass index (BMI) (50.1± 10.8 kg/m2), and pCO2 (7.3±0.9 kPa). NRDI was assessed by surface electromyogram of the parasternal intercostals. Cardiac function was assessed by transthoracic echocardiography (TTE). All measurements were performed at baseline, 6 weeks, and 3 months.
Results: NRDI improved on day one following NIV set-up comparing to baseline (484.2±214.8 vs. 316.5±106.5 AU) and this improvement was maintained at 6 weeks (369.1±173.2 AU) and at 3 months (351.2±167.1 AU) (P=0.004). No significant differences were identified in terms of cardiac function between baseline and 3 months [tricuspid annular plane systolic excursion (TAPSE) (24.6±5.8 vs. 23.0±4.0 mm, P=0.317); systolic pulmonary artery (PA) pressures (36.7±15.2 vs. 44.5±23.9 mmHg, P=0.163].
Conclusions: NIV improves NRDI in patients with OHS, while the cardiac function over a three-month period remains unchanged.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/18590}
}